Silverback Therapeutics, Inc. (51) | Business Operations (4)
Browse by Subcategory
Recent Contracts
-
Collaboration and License Agreement, dated as of April 30, 2020, by and between ARS Pharmaceuticals, Inc. and Alfresa Pharma Corporation
(Filed With SEC on November 8, 2022)
-
Master Laboratory Services Agreement, by and between the registrant and Q Squared Solutions LLC, dated May 25, 2020
(Filed With SEC on November 10, 2020)
-
Collaboration and Distribution Agreement, dated as of March 1, 2021, by and between ARS Pharmaceuticals, Inc. and Pediatrix Therapeutics
(Filed With SEC on November 8, 2022)
-
Master Services Agreement, by and between the registrant and CE3, Inc., dated January 21, 2020
(Filed With SEC on November 10, 2020)